US space agency NASA says no to in-house or third-party NFTs
Raffaele Redi •
GLPG
GLPG
Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes novel medicines. Its clinical stage programs include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn's disease, Phase 2/3 trials for ulcerative colitis, and Phase II trials for multiple additional indications; GLPG1690, an autotaxin inhibitor, which is in Phase III clinical trial for the treatment of idiopathic pulmonary fibrosis; GLPG1972 that completed Phase 1b clinical trial for the treatment of osteoarthritis; and MOR106, which is in Phase II trials for atopic dermatitis patients. The company has collaboration agreement with Gilead Sciences, Inc. for the development of filgotinib for inflammatory indications; Servier to develop GLPG1972; and AbbVie for the discovery, development, and commercialization of potentiator and corrector molecules for the treatment of cystic fibrosis, as well as with MorphoSys for MOR106. Galapagos NV was founded in 1999 and is headquartered in Mechelen, Belgium.
White Paper Declaration
White Paper Declaration
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in
GLPG price history
| Date | Close | Change | Change(%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 26, 2022 | 46.70 | 0.20 | 0.43% | 46.50 | 47.20 | 46.35 |
| Jan 25, 2022 | 46.45 | -1.15 | -2.42% | 47.60 | 47.85 | 46.15 |
| Jan 24, 2022 | 47.45 | -2.85 | -5.67% | 50.30 | 50.90 | 47.15 |
| Jan 21, 2022 | 50.45 | 0.75 | 1.51% | 49.70 | 50.60 | 49.10 |
| Jan 20, 2022 | 49.70 | 1.70 | 3.54% | 48.00 | 50.05 | 48.00 |
| Jan 19, 2022 | 47.75 | -0.15 | -0.31% | 47.90 | 48.00 | 46.85 |
| Jan 18, 2022 | 48.05 | -0.90 | -1.84% | 48.95 | 50.10 | 48.05 |
| Jan 17, 2022 | 49.15 | 1.05 | 2.18% | 48.10 | 50.15 | 48.10 |
| Jan 14, 2022 | 47.45 | 0.85 | 1.82% | 46.60 | 47.95 | 46.50 |
| Jan 13, 2022 | 46.05 | 0.25 | 0.55% | 45.80 | 46.40 | 45.10 |
| Jan 12, 2022 | 46.05 | 0.40 | 0.88% | 45.65 | 46.75 | 45.60 |
| Jan 11, 2022 | 45.60 | 0.85 | 1.90% | 44.75 | 45.80 | 44.50 |
| Jan 10, 2022 | 44.70 | -1.05 | -2.30% | 45.75 | 46.00 | 44.45 |
| Jan 7, 2022 | 45.85 | 0.20 | 0.44% | 45.65 | 46.50 | 45.15 |
| Jan 6, 2022 | 45.60 | -0.30 | -0.65% | 45.90 | 46.05 | 44.80 |
| Jan 5, 2022 | 46.05 | -1.90 | -3.96% | 47.95 | 47.95 | 46.00 |
| Jan 4, 2022 | 48.10 | 0.40 | 0.84% | 47.70 | 49.05 | 47.40 |
| Jan 3, 2022 | 47.20 | -1.95 | -3.97% | 49.15 | 49.15 | 46.75 |
| Dec 31, 2021 | 48.95 | 0.05 | 0.10% | 48.90 | 49.10 | 48.30 |
| Dec 30, 2021 | 48.90 | 1.35 | 2.84% | 47.55 | 49.00 | 47.50 |